Streetbeat News

Products Services

SPRC

SciSparc shares rose following the submission of an IND application to the FDA for a Phase IIb trial of SCI-110, aimed at treating Tourette syndrome.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 8:12 pm

SPRC

SciSparc has submitted an Investigational New Drug (IND) application to the FDA for a Phase IIb trial of their drug SCI-110, aimed at treating Tourette Syndrome. This marks a significant step in the development of their treatment pipeline.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 8:10 pm

AAPL

Apple is expanding its production beyond China to India and Southeast Asia as part of its 'China+1' strategy. This move aims to diversify production amid geopolitical tensions, with significant shifts in iPhone, AirPods, and Apple Watch production. However, the transition faces challenges, including lower margins in India and slow component relocation from China.

Portfolio Pulse from Surbhi Jain

September 18, 2024 | 8:08 pm

FDMT

4D Molecular Therapeutics (FDMT) presented positive clinical data for its 4D-150 treatment for wet AMD, showing significant reduction in injections and a favorable safety profile. The company is planning a Phase 3 program to enhance its clinical and commercial success.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 8:07 pm

PLTK

Playtika has agreed to acquire SuperPlay, a mobile gaming company, for $700 million with additional contingent consideration of up to $1.25 billion. This acquisition is expected to bring an experienced team to Playtika and drive significant growth.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 8:07 pm

ELVN

Enliven Therapeutics will present updated Phase 1a data for their ELVN-001 treatment at the 26th Annual John Goldman Conference on CML. This presentation could provide insights into the progress and potential of ELVN-001 in treating chronic myeloid leukemia.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 8:06 pm

QGEN

QIAGEN has expanded its QIAcuity Digital PCR offering by adding over 100 new assays through the GeneGlobe platform. This expansion supports various fields including cancer research, genetic disorders, infectious disease surveillance, and environmental monitoring.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 8:06 pm

BP

PLUG

Plug Power has signed an agreement with a joint venture between BP and Iberdrola to supply 25 MW of PEM electrolyzers for BP's Castellón Refinery Project in Valencia, Spain. This deal highlights Plug Power's growing role in the hydrogen energy sector.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 8:03 pm

AMZN

EA

Electronic Arts Inc (EA) is shifting its focus from releasing Sims 5 to expanding The Sims 4 and developing new projects like Project Rene. EA is also working on a Sims movie with Amazon MGM Studios and increasing its reliance on AI for game development.

Portfolio Pulse from Franca Quarneti

September 18, 2024 | 7:45 pm

ZBH

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) will phase out its CPT Hip System by the end of 2024 due to high fracture risks, following an FDA warning. The system has a higher fracture rate compared to similar devices, prompting a recall and updated usage instructions.

Portfolio Pulse from Vandana Singh

September 18, 2024 | 7:40 pm